Additive Solutions for the Suspension of Blood Products Framework Agreement
NHS Blood and Transplant · Awarded
- Buyer
- NHS Blood and Transplant
- Status
- Awarded
- Country
- United Kingdom
- Region
- England
- Sector
- Manufacturing
- Reference
- FaT-ocds-h6vhtk-03ef7d
- Published
- 2023-12-20
- Deadline
- 2026-04-19
Tender summary
Establishment of a Framework Agreement with the following Blood Establishments as beneficiaries - NHS Blood and Transplant; the Welsh Blood Service (WBS); the Northern Ireland Blood Transfusion Service (NIBTS); the Scottish National Blood Transfusion Service (SNBTS); the Australian Red Cross Lifeblood (ARCL), the New Zealand Blood Service (NZBS) and the Irish Blood Transfusion Service (IBTS). Additive Solutions for the Suspension of Blood Products: Lot 1: Additive solution for the suspension of pooled platelets, granulocytes and other components derived from whole blood; Additive solution for…
This is a public summary of a procurement notice. Dates and status reflect the notice held by BidScout; check the full notice before bidding.
Full tender details have a three-minute guest preview for open opportunities. AI insights require registration.
Register for full access